3.18MMarket Cap0.04P/E (TTM)
2.190High2.118Low21.25KVolume2.120Open2.180Pre Close45.65KTurnover1.46%Turnover RatioLossP/E (Static)1.49MShares8.55052wk High1.05P/B3.12MFloat Cap1.83552wk Low--Dividend TTM1.46MShs Float1590.000Historical High--Div YieldTTM3.30%Amplitude1.835Historical Low2.148Avg Price1Lot Size
Tharimmune Stock Forum
📊⚡️📊
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
Friday, 6th December at 4:15 pm
BRIDGEWATER, NEW JERSEY / ACCESSWIRE / December 6, 2024 / Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced it has entered into a securities purchase agreement to raise gross proceeds of approximately $2.02 million throug...
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune (NASDAQ:THAR) presented Phase 1 clinical data for TH104 at AASLD The Liver Meeting 2024. The trial evaluated TH104 transmucosal buccal film in patients with chronic liver disease (CLD) for chronic pruritus treatment.
The study showed significant correlation between blood levels and symptom relief, with a correlation coeff...
No comment yet